MBOAT7 and neoplasm: A previous report in April 2020 showed that the MBOAT7 gene could be restricted to reduce the content of arachidonic acid-containing phosphatidylinositol pools in KIRC by altering the lipid metabolism of tumor cells, thereby producing a therapeutic effect (Neumann et al., 2020).